[1] Massarweh NN, El Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24(3): 1073274817729245.
[2] Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma[J]. Semin Diagn Pathol, 2017, 34(2): 153-159.
[3] Wen S, Liu Y, Yang M, et al. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation[J]. Oncol Rep, 2016, 36(4): 2193-2199.
[4] Tricoli L, Niture S, Chimeh U, et al. Role of microRNAs in the development of hepatocellular carcinoma and drug resistance[J]. Front Biosci (Landmark Ed), 2019, 24(1): 382-391.
[5] Shaheen R, Hashem A, AbdelSalam GM, et al. Mutations in CIT, encoding citron rhointeracting serine/threonine kinase, cause severe primary microcephaly in humans[J]. Hum Genet, 2016, 135(10): 11911197.
[6] Sahin I, Kawano Y, SklavenitisPistofidis R, et al. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma[J]. Blood Adv, 2019, 3(7): 995-1002.
[7] Meng D, Yu Q, Feng L, et al. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism[J]. Clin Transl Oncol, 2019, 21(7): 910-923.
[8] Praharaj PP, Naik PP, Panigrahi DP, et al. Intricate role of mitochondrial lipid in mitophagy and mitochondrial apoptosis: its implication in cancer therapeutics[J]. Cell Mol Life Sci, 2019, 76(9): 1641-1652.
[9] Chen HP, Xiang Q, Liu DW, et al. CIT gene silencing can inhibit the proliferation and metastasis of prostate cancer cells [J]. Journal of Southern Medical University, 2019, 39 (3):7-13.(in Chinese)
陈海平, 向玘, 刘大伟, 等. 沉默CIT基因可抑制前列腺癌细胞的增殖和转移(英文)[J]. 南方医科大学学报, 2019,39(3):7-13.
[10] Xiang XH, Yang L, Zhang X, et al. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2019, 25(14): 1715-1728.
[11] Huang GL, Feng WW, Huang ZS, et al. Effects of matrine on drug resistance of drug-resistant HCC cell line HepG2/ADM chemotherapy through mitochondrial apoptosis pathway [J]. Chinese Journal of Hepatology, 2019, 27(3):216-218. (in Chinese)
黄桂柳, 冯巍巍, 黄赞松, 等. 苦参素通过线粒体凋亡通路影响肝癌耐药细胞株HepG2/ADM化学治疗的耐药性[J]. 中华肝脏病杂志, 2019, 27(3):216-218.]
[12] Fu Y, Huang J, Wang KS, et al. RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells[J]. Mol Biol Rep, 2011, 38(2): 693-702.
[13] Sun H, Cui C, Xiao F, et al. miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON[J]. Hepatol Res, 2015, 45(12): 1312-1322.
[14] Hu Y, Liu Q, Zhou XF, et al. Screening of CIT gene siRNA interference sequence and its inhibitory expression in liver cancer sk-hep-1 [J]. Chinese Journal of Liver Diseases, 2019, 27(4): 281-285. (in Chinese)
胡月, 刘杞, 周晓芳, 等. CIT基因siRNA干扰序列的筛选及其在肝癌SK-Hep-1中的抑制表达[J]. 中国肝脏病杂志, 2019, 27(4): 281-285.
[15] Wang XQ, Li RP, Sun YZh, et al. Chronic cold exposure and changes in mitochondrial number [J]. Acta Anatomica Sinica, 2017, 48(3): 254-259. (in Chinese)
王小青, 李瑞萍, 孙仪征, 等.慢性寒冷暴露与线粒体数量改变[J]. 解剖学报, 2017, 48(3): 254-259.
[16] Cui Q, Wen S, Huang P. Targeting cancer cell mitochondria as a therapeutic approach: recent updates[J]. Future Med Chem, 2017, 9(9): 929-949.
[17] Guerra F, Arbini AA, Moro L. Mitochondria and cancer chemoresistance [J]. Biochim Biophys Acta Bioenerg, 2017, 1858(8): 686-699.
[18] Yan C, Li TS. Dual role of mitophagy in cancer drug resistance[J]. Anticancer Res, 2018, 38(2): 617-621.
[19] Altieri DC. Mitochondria on the move: emerging paradigms of organelle trafficking in tumour plasticity and metastasis[J]. Br J Cancer, 2017, 117(3): 301-305.
[20] Yan B, Dong L, Neuzil J. Mitochondria: an intriguing target for killing tumour-initiating cells[J]. Mitochondrion, 2016, 26(1): 86-93.
[21] Idelchik MDPS, Begley U, Begley TJ, et al. Mitochondrial ROS control of cancer[J]. Semin Cancer Biol, 2017, 47(12): 57-66.
|